{"filing":{"accession_number":"0001193125-26-304964","cik":"0001661998","ticker":"QTTB","company_name":"Q32 Bio Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"d150730d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312526304964/d150730d8k.htm"},"events":[{"id":18216,"run_id":16367,"accession_number":"0001193125-26-304964","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Q32 Bio entered into an underwriting agreement to issue 6,027,399 shares of common stock at $18.25 per share and 4,931,506 pre-funded warrants, raising approximately $187.6 million (or $215.8 million with optional shares exercised). This is a material registered public offering of equity securities that will dilute existing shareholders and is a significant capital-raising event for the company's clinical development efforts.","company_name":"Q32 Bio Inc.","ticker":"QTTB","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16959,"accession_number":"0001193125-26-304964","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Q32 Bio entered into an underwriting agreement to issue 6,027,399 shares of common stock at $18.25 per share and 4,931,506 pre-funded warrants, raising approximately $187.6 million (or $215.8 million with optional shares exercised). This is a material registered public offering of equity securities that will dilute existing shareholders and is a significant capital-raising event for the company's clinical development efforts.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:19:39.833860+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16959,"accession_number":"0001193125-26-304964","item_number":"1.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Q32 Bio entered into an underwriting agreement to issue 6,027,399 shares of common stock at $18.25 per share and 4,931,506 pre-funded warrants, raising approximately $187.6 million (or $215.8 million with optional shares exercised). This is a material registered public offering of equity securities that will dilute existing shareholders and is a significant capital-raising event for the company's clinical development efforts.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:19:39.833860+00:00","company_name":"Q32 Bio Inc.","ticker":"QTTB","filing_date":"2026-07-15"}]}